How prosthetic foot stiffness affects outcomes after a below-knee amputation with bone-anchored or socket prostheses

Influence of Prosthetic Foot Stiffness on Transtibial Osseointegrated Bone-Anchored Limb Outcomes

Phase 1 Interventional University of Colorado, Denver · NCT07263945

This trial will test whether using a softer, your usual, or a stiffer prosthetic foot changes comfort, walking function, and bone‑implant loading for adults with a single below‑knee amputation who use either a bone‑anchored limb or a socket prosthesis.

Quick facts

PhasePhase 1
Study typeInterventional
Enrollment60 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity of Colorado, Denver Academic / other
Locations1 site (Aurora, Colorado)
Trial IDNCT07263945 on ClinicalTrials.gov

What this trial studies

This is a crossover interventional trial comparing people with unilateral transtibial amputation who use osseointegrated bone‑anchored limbs versus those who use standard socket prostheses. Each participant will complete walking and daily‑living tasks with three foot conditions: their prescribed foot, a foot two stiffness categories softer, and a foot two categories stiffer. Outcomes include dynamic bone‑implant loading, multi‑joint biomechanics, function and pain measures, osseoperception, and fall risk. Results will be used to identify target ranges of foot stiffness that produce optimal biomechanical and clinical outcomes.

Who should consider this trial

Good fit: Adults (≥18 years) with a unilateral transtibial amputation from nonvascular causes who can walk unassisted for 5 minutes and are at least 12 months post‑amputation (or ≥12 months after osseointegration surgery for the bone‑anchored group) using a low‑profile prosthetic foot.

Not a fit: People with vascular‑cause amputations, major contralateral amputation, neurologic balance disorders, regular need for assistive devices for community ambulation, inflammatory disease or diabetes, or who are pregnant or breastfeeding are unlikely to be eligible or to benefit from this protocol.

Why it matters

Potential benefit: If successful, identifying optimal foot stiffness could improve comfort and function, reduce harmful bone‑implant loading, and lower fall risk for people with below‑knee osseointegrated limbs.

How similar studies have performed: Some prior work has examined foot stiffness effects in socket prosthesis users, but there is little prior evidence specifically addressing how foot stiffness affects outcomes in osseointegrated bone‑anchored limbs, making this approach relatively novel for that population.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Unilateral transtibial amputation due to traumatic, congenital, or cancer-related causes
* \> 12-months bone-anchored limb implantation surgery (Bone Anchored Limb group)
* \> 12-months limb amputation (Socket Control group)
* Non-vascular amputation etiology
* Low profile prosthetic foot (nominal)
* Can walk unassisted for 5-minutes
* \> 18 years old

Exclusion Criteria:

* Major amputation on contralateral limb
* Vascular amputation etiology
* Neurologic pathology that impairs coordination/balance
* Regular assistive device use required for community ambulation
* Inflammatory diseases or diabetes
* Pregnancy or breastfeeding

Where this trial is running

Aurora, Colorado

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions AmputationTranstibial Amputation - UnilateralBone Anchored DevicesOsseointegrationamputationbone anchored limbosseointegrationtranstibial amputation
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.